Skip to main content
. 2021 Sep 17;14(9):935. doi: 10.3390/ph14090935

Table 2.

The results of the post-hoc analyses of serum metabolites.

Serum
No Metabolite Post Hoc Test p-Values
C vs. PD C vs. APDs PD vs. APDs
1 C18:2 a 0.049849 NS NS
2 Ornithine a 0.045345 NS NS
3 Tyrosine b 0.015431 NS NS
4 Putrescine b 0.004395 0.011878 NS
5 Spermidine a 0.013458 0.000915 NS
6 t4-OH-Proline b 0.006106 0.00141 NS
7 Total DMA a NS 0.001545 NS
8 lysoPC a C28:0 b NS NS 0.041845
9 lysoPC a C28:1 b 0.038853 NS NS
10 PC aa C34:4 a NS NS 0.042019
11 PC aa C38:1 a NS 0.008727 NS
12 PC ae C36:4 a NS 0.00344 NS
13 PC ae C38:4 a NS 0.046699 NS
14 PC ae C38:5 a NS 0.007192 NS

a ANOVA; b Kruskal–Wallis; NS—not significant; C—control; PD—Parkinson’s disease; APDs—atypical parkinsonian disorders; DMA—dimethylarginine; C18:2—octadecadienylcarnitine; PC aa/ae C X:Y—diacyl(aa)/acyl-alkyl (ae) phosphatidylcholine with the total number of carbon atoms denoted by X and the number of double bonds indicated by Y.